Doxorubicin- and Cyclophosphamide-Based Chemotherapy for Pregnant Women With Stage IIIa Breast Cancer

Am J Ther. 2021 Jan 13;29(1):e120-e122. doi: 10.1097/MJT.0000000000001316.

Authors

Remi Kuchira^{1

2}, Kenji Momo¹, Haruka Isozaki^{1

2}, Hiromi Koshizuka^{1

2}, Masaki Kida^{1

2}, Ayako Watanabe^{1

2}, Chie Nagashima³, Yuka Kashiwabara^{1

2}, Katsumi Tanaka^{1

2}, Ken Shimada⁴, Katsufumi Otsuki⁵, Miwa Yoshida⁶, Tadanori Sasaki^{1

7}

Affiliations

¹ Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan.
² Department of Pharmacy, Showa University Koto Toyosu Hospital, Tokyo, Japan.
³ Departments of Nursing.
⁴ Medical Oncology.
⁵ Obstetrics and Gynecology, and.
⁶ Breast Surgical Oncology, Showa University Koto Toyosu Hospital, Tokyo, Japan.
⁷ Department of Pharmacy, Showa University Hospital, Tokyo, Japan.

PMID: 33491966
DOI: 10.1097/MJT.0000000000001316

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Breast Neoplasms* / drug therapy
Chemotherapy, Adjuvant
Cyclophosphamide / therapeutic use
Doxorubicin / therapeutic use
Female
Humans
Neoplasm Staging
Pregnancy
Pregnant Women

Substances

Doxorubicin
Cyclophosphamide